Decreased renal corin expression contributes to sodium retention in proteinuric kidney diseases

Kidney International

Volumn 78, Issue 7, 2010, Pages 650-659

  Polzin, Danny ^a   Kaminski, Henriette J ^a   Kastner, Christian ^a   Wang, Wei ^b   Krämer, Stephanie ^a   Gambaryan, Stepan ^c   Russwurm, Michael ^d   Peters, Harm ^a   Wu, Qingyu ^b   Vandewalle, Alain ^e   Bachmann, Sebastian ^a   Theilig, Franziska ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

epithelial sodium transport; hypertension; nephrotic syndrome; proteinuria; tubule cells

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA EPITHELIAL SODIUM CHANNEL; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE 2; EPITHELIAL SODIUM CHANNEL; PHOSPHODIESTERASE V; PROTEIN CORIN; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULONEPHRITIS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MALE; MICROARRAY ANALYSIS; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; RAT; SODIUM RETENTION;

EID: 77956873615     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.197     Document Type: Article

References (45)

1. Ichikawa I, Rennke HG, Hoyer JR et al. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 1983; 71: 91-103.
2. Buerkert J, Martin DR, Trigg D et al. Sodium handling by deep nephrons and the terminal collecting duct in glomerulonephritis. Kidney Int 1991; 39: 850-857.
3. Kim SW, Wang W, Nielsen J et al. Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats. Am J Physiol 2004; 286: F922-F935.
4. Deschenes G, Doucet A. Collecting duct (Na+/K+)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes. J Am Soc Nephrol 2000; 11: 604-615.
5. Gadau J, Peters H, Kastner C et al. Mechanisms of tubular volume retention in immune-mediated glomerulonephritis. Kidney Int 2009; 75: 699-710.
6. Kastner C, Pohl M, Sendeski M et al. Effects of receptor-mediated endocytosis and tubular protein composition on volume retention in experimental glomerulonephritis. Am J Physiol 2009; 296: F902-F911.
7. Audigé A, Yu ZR, Frey BM et al. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside- induced nephrotic syndrome. Clin Sci 2003; 104: 389-395.
8. Lourdel S, Loffing J, Favre G et al. Hyperaldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis. J Am Soc Nephrol 2005; 16: 3642-3650.
9. Carattino MD, Hughey RP, Kleyman TR. Proteolytic processing of the epithelial sodium channel g subunit has a dominant role in channelactzivation. J Biol Chem 2008; 283: 25290-25295.
10. Hughey RP, Carattino MD, Kleyman TR. Role of proteolysis in the activation of epithelial sodium channels. Curr Opin Nephrol Hypertens 2007; 16: 444-450.
11. Svenningsen P, Bistrup C, Friis UG et al. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol 2009; 20: 299-310.
12. Rossier BC, Stutts MJ. Activation of the epithelial sodium channel (ENaC) by serine proteases. Annu Rev Physiol 2009; 71: 361-379.
13. Deschênes G, Wittner M, Stefano A et al. Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy. J Am Soc Nephrol 2001; 12: 598-601.
14. Doucet A, Favre G, Deschênes G. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. Pediatr Nephrol 2007; 22: 1983-1990.
15. Pyo HJ, Summer SN, Niederberger M et al. Arginine vasopressin gene expression in rats with puromycin-induced nephrotic syndrome. Am J Kidney Dis 1995; 25: 58-62.
16. Ni Z, Vaziri ND. Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria. Biochim Biophys Acta 2003; 1638: 129-137. (Pubitemid 36829270)
17. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
18. Valentin JP, Ying WZ, Couser WG et al. Extrarenal resistance to atrial natriuretic peptide in rats with experimental nephrotic syndrome. Am J Physiol 1998; 274(3 Part 2): F556-F563.
19. Perico N, Delaini F, Lupini C et al. Blunted excretory response to atrial natriuretic peptide in experimental nephrosis. Kidney Int 1989; 36: 57-64.
20. Yan W, Wu F, Morser J et al. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. PNAS 2000; 97: 8525-8529.
21. Chan JCY, Knudson O, Wu F et al. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. PNAS 2005; 102: 785-790.
22. Yan W, Sheng N, Seto M et al. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem 1999; 274: 14926-14935.
23. Barrett PQ, Isales CM The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion. Endocrinology 1988; 122: 799-808.
24. Terada Y, Moriyama T, Martin BM et al. RT-PCR microlocalization of mRNA for guanylyl cyclase-coupled ANF receptor in rat kidney. Am J Physiol 1991; 261(6 Part 2): F1080-F1087.
25. Zhao D, Pandey KN, Navar LG. ANP-mediated inhibition of distal nephron fractional sodium reabsorption in wild-type and mice overexpressing natriuretic peptide receptor. Am J Physiol 2010; 298: F103-F108.
26. Brenner BM, Ballermann BJ, Gunning ME et al. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990; 70: 665-699.
27. McAllister-Lucas LM, Sonnenburg WK, Kadlecek A et al. The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. J Biol Chem 1993; 268: 22863-22873.
28. Loffing J, Korbmacher C. Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC). Pflügers Arch 2009; 458: 111-135.
29. Lu C, Pribanic S, Debonneville A et al. The PY motif of ENaC, mutated in liddle syndrome, regulates channel internalization, sorting and mobilization from subapical pool. Traffic 2007; 8: 1246-1264.
30. Shi SJ, Vellaichamy E, Chin SY et al. Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am J Physiol 2003; 285: F694-F702.
31. Wilson LS, Elbatarny HS, Crawley SW et al. Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions. Proc Natl Acad Sci USA 2008; 105: 13650-13655.
32. Nie HG, Zhang W, Han DY et al. 8-pCPT-cGMP stimulates {alpha}{beta}{gamma}-ENaC activity in oocytes as an external ligand requiring specific nucleotide moieties. Am J Physiol 2010; 298: F323-F334.
33. Light DB, Corbin JD, Stanton BA. Dual ion-channel regulation by cyclic GMP and cyclic GMP-dependent protein kinase. Nature 1990; 344: 336-339.
34. Rodŕguez-Iturbe B, Ferrebuz A, Vanegas V et al. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int 2005; 68: 2131-2342.
35. Nonoguchi H, Sands JM, Knepper MA. Atrial natriuretic factor inhibits vasopressin-stimulated osmotic water permeability in rat inner medullary collecting duct. J Clin Invest 1988; 82: 1383-1390.
36. Nonoguchi H, Sands JM, Knepper MA. ANF inhibits NaCl and fluid absorption in cortical collecting duct of rat kidney. Am J Physiol 1989; 256(1 Part 2): F179-F186.
37. Rouch AJ, Chen L, Troutman SL et al. Na+ transport in isolated rat CCD: effects of bradykinin, ANP, clonidine, and hydrochlorothiazide. Am J Physiol 1991; 260(1 Part 2): F86-F95.
38. Schlatter E, Cermak R, Forssmann WG et al. cGMP-activating peptides do not regulate electrogenic electrolyte transport in principal cells of rat CCD. Am J Physiol 1996; 271(6 Part 2): F1158-F1165.
39. Gambaryan S, Butt E, Marcus K et al. cGMP-dependent protein kinase type II regulates basal level of aldosterone production by zona glomerulosa cells without increasing expression of the steroidogenic acute regulatory protein gene. J Biol Chem 2003; 278: 29640-29648.
40. Bens M, Vallet V, Cluzeaud F et al. Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line. J Am Soc Nephrol 1999b; 10: 923-934.
41. Mullershausen F, Russwurm M, Koesling D et al. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation. Mol Biol Cell 2004; 15: 4023-4030.
42. Koltes JE, Mishra BP, Kumar D et al. A nonsense mutation in cGMP-dependent type II protein kinase (PRKG2) causes dwarfism in American Angus cattle. Proc Natl Acad Sci USA 2009; 106: 19250-19255.
43. Brodsky FM Clathrin structure characterized with monoclonal antibodies. II. Identification of in vivo forms of clathrin. J Cell Biol 1985; 101: 2055-2062.
44. Eigenthaler M, Nolte C, Halbrügge M et al. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur J Biochem 1992; 205: 471-481.
45. Theilig F, Bostanjoglo M, Pavenstädt H et al. Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver. J Am Soc Nephrol 2001; 12: 2209-2220.